Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2017 06:00 ET | Source: Athersys, Inc.

Athersys Reports Alignment of Key Regulators for Pivotal Registration Study in Stroke

MultiStem® stem cell technology receives Positive Opinion from European Medicines Agency Adds to Special Protocol Assessment and Fast Track designation in U.S., and Priority Review under Sakigake...
September 12, 2016 06:30 ET | Source: Athersys, Inc.

Athersys Announces Acceptance by PMDA of Clinical Trial Notification in Japan for Treatment of Ischemic Stroke With MultiStem®

CLEVELAND, Sept. 12, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) announced today the successful completion of Japan’s Pharmaceutical and Medical Devices Agency (PMDA) review of the...